D. Baylink

发表

Genetic variability in adult bone density among inbred strains of mice.

L. Donahue, C. Rosen, D J Baylink, 1996, Bone.

Cortical tibial bone volume in two strains of mice: effects of sciatic neurectomy and genetic regulation of bone response to mechanical loading.

L. Donahue, J. Wergedal, H. Dimai, 1999, Bone.

Genetic Regulation of Cortical and Trabecular Bone Strength and Microstructure in Inbred Strains of Mice

R Müller, M. Bouxsein, L. Donahue, 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Role of Osteocyte-derived Insulin-Like Growth Factor I in Developmental Growth, Modeling, Remodeling, and Regeneration of the Bone

K. Lau, D. Baylink, M. Sheng, 2014, Journal of bone metabolism.

Sequence comparison and predicted structure for the four exon-encoded regions of human insulin-like growth factor binding protein 4.

S. Mohan, D. Baylink, E. Landale, 1995, Growth factors.

Antisense Oligodeoxynucleotide Evidence That a Unique Osteoclastic Protein‐Tyrosine Phosphatase Is Essential for Osteoclastic Resorption

K. Lau, D. Baylink, S. Suhr, 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Effect of low-dose of recombinant human growth hormone on bone metabolism in elderly women with osteoporosis.

S. Mohan, K. Chihara, S. Yano, 2002, European journal of endocrinology.

Studies on the regulation of insulin‐like growth factor binding protein 3 secretion in human osteosarcoma cells in vitro

S. Mohan, S. Hilliker, D. Baylink, 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Dibutyryl cyclic adenosine monophosphate differentially regulates cell proliferation in low and high alkaline phosphatase SaOS‐2 human osteosarcoma cells: Evidence for mediation by the insulin‐like growth factor‐II system

K. Lee, S. Mohan, S. Hilliker, 1993, Journal of cellular physiology.

Castrated men exhibit bone loss: effect of calcitonin treatment on biochemical indices of bone remodeling.

D. Baylink, J. Stepan, M. Lachman, 1989, The Journal of clinical endocrinology and metabolism.

Effect of calcitonin on the rates of bone formation and resorption in the rat.

C. Rich, D. Baylink, E. Morey, 1969, Endocrinology.

Basal plasma immunoreactive calcitonin in postmenopausal osteoporosis.

W. Nelp, B. Roos, C. Chesnut, 1980, Metabolism: clinical and experimental.

DEFICIENT CALCITONIN RESPONSE TO CALCIUM STIMULATION IN POSTMENOPAUSAL OSTEOPOROSIS?

B. Roos, C. Chesnut, D. Baylink, 1982, The Lancet.

Effects of Secreted Frizzled‐Related Protein 3 on Osteoblasts In Vitro

S. Mohan, Y. Amaar, Yoon-Sok Chung, 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Regulation of serum 1alpha,25-dihydroxyvitamin D3 by calcium and phosphate in the rat

J. Wergedal, D. Baylink, D. Baylink, 1975, Science.

Influence of phosphate depletion on the biosynthesis and circulating level of 1alpha,25-dihydroxyvitamin D.

M. Haussler, D. Baylink, D. Cork, 1977, Advances in experimental medicine and biology.

Calcium and phosphorus deficiency in rats: effects on PTH and 1,25-dihydroxyvitamin D3.

M. Haussler, J. I. Rader, D. Baylink, 1979, The American journal of physiology.

Novel loci regulating bone anabolic response to loading: expression QTL analysis in C57BL/6JXC3H/HeJ mice cross.

S. Mohan, C. Kesavan, D. Baylink, 2007, Bone.

Histomorphometric studies show that bone formation and bone mineral apposition rates are greater in C3H/HeJ (high-density) than C57BL/6J (low-density) mice during growth.

L. Donahue, K. Lau, J. Wergedal, 1999, Bone.

Growth factors for bone growth and repair: IGF, TGF beta and BMP.

S. Mohan, D. Baylink, T. Linkhart, 1996, Bone.

Embryonic bone matrix formation is increased after exposure to a low-amplitude capacitively coupled electric field, in vitro.

W. R. Adey, D. Baylink, J. Farley, 1986, Biochimica et biophysica acta.

Growth Hormone Axis-Independent Growth. A Case Report 438

S. Mohan, E. Hathout, D. Baylink, 1998, Pediatric Research.

Decrease in serum immunoreactive parathyroid hormone in rats and in parathyroid hormone secretion in vitro by 1,25-dihydroxycholecalciferol.

J. Wergedal, A. Norman, D. Baylink, 1975, The Journal of clinical investigation.

Phenytoin at Micromolar Concentrations is an Osteogenic Agent for Human-mandible-derived Bone Cells in vitro

O. Nakade, K. Lau, D. Baylink, 1995, Journal of dental research.

Role of Insulin-Like Growth Factor Binding Proteins and Their Proteases

S. Mohan, D. Baylink, S. Rajaram, 1997 .

Osteocyte-derived insulin-like growth factor I is essential for determining bone mechanosensitivity.

L. Bonewald, R. Müller, K. Lau, 2013, American journal of physiology. Endocrinology and metabolism.

Leptin Receptor (Lepr) Is a Negative Modulator of Bone Mechanosensitivity and Genetic Variations in Lepr May Contribute to the Differential Osteogenic Response to Mechanical Stimulation in the C57BL/6J and C3H/HeJ Pair of Mouse Strains*

S. Mohan, K. Lau, C. Kesavan, 2010, The Journal of Biological Chemistry.

Pregnancy-associated plasma protein-A increases osteoblast proliferation in vitro and bone formation in vivo.

S. Mohan, J. Wergedal, D. Baylink, 2006, Endocrinology.

Extracellular signal-regulated kinase-1 and -2 are both essential for the shear stress-induced human osteoblast proliferation.

K. Lau, Shin-Tai Chen, D. Baylink, 2004, Bone.

Ovariectomy selectively reduces the concentration of transforming growth factor beta in rat bone: implications for estrogen deficiency-associated bone loss.

L. Demers, N. Bell, D. Baylink, 1992, Proceedings of the National Academy of Sciences of the United States of America.

Prevention of bone loss with tibolone in postmenopausal women: results of two randomized, double-blind, placebo-controlled, dose-finding studies.

J. Gallagher, M. McClung, D. Baylink, 2001, The Journal of clinical endocrinology and metabolism.

Prevention of Bone Loss With Tibolone in Postmenopausal Women: Results of Two Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Studies

J. Gallagher, M. McClung, D. Baylink, 2002 .

Bone cells on microcarrier spheres.

J. Puzas, G. Howard, R. Turner, 1983, JAMA.

Quantitation of growth factors IGF‐I, SGF/IGF‐II, and TGF‐β in human dentin

S. Mohan, S. Jepsen, D. Baylink, 1990 .

Quantitation of growth factors IGF-I, SGF/IGF-II, and TGF-beta in human dentin.

S. Mohan, S. Jepsen, D. Baylink, 1990, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Local administration of AAV-DJ pseudoserotype expressing COX2 provided early onset of transgene expression and promoted bone fracture healing in mice

K. Lau, Xiaolei Tang, R. Lakhan, 2015, Gene Therapy.

CHAPTER 19 – Role of Growth Hormone/Insulin-like Growth Factor Axis

S. Mohan, D. Baylink, 1999 .

Effects of zinc and other nutritional factors on insulin-like growth factor I and insulin-like growth factor binding proteins in postmenopausal women.

S. Mohan, A. Devine, C. Rosen, 1998, The American journal of clinical nutrition.

Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions.

S. Mohan, D. Baylink, S. Rajaram, 1997, Endocrine reviews.

Effects of zinc and other nutritional factors on insulin-like growth factor I and insulin-like growth factor binding proteins in postmenopausal women 1 – 3

S. Mohan, A. Devine, R. Prince, 2022 .

Insulin-like growth factor-binding protein-5 induces a gender-related decrease in bone mineral density in transgenic mice.

S. Mohan, D. Salih, J. Wergedal, 2005, Endocrinology.

Effects of short term administration of recombinant human growth hormone to elderly people.

R. Marcus, B. Sherman, G. Butterfield, 1990, The Journal of clinical endocrinology and metabolism.

S. Mohan, P. Bettica, D. Baylink, 1994, The Journal of clinical endocrinology and metabolism.

The insulin-like growth factor system and the coupling of formation to resorption.

S. Mohan, D. Baylink, J. Hayden, 1995, Bone.

Genetic variation in bone-regenerative capacity among inbred strains of mice.

S. Mohan, D. Baylink, C. Rundle, 2001, Bone.

Human prostatic cancer cells, PC3, elaborate mitogenic activity which selectively stimulates human bone cells.

S. Mohan, D. Baylink, T. Linkhart, 1990, Cancer research.

Skeletal growth factor and other growth factors known to be present in bone matrix stimulate proliferation and protein synthesis in human bone cells

S. Mohan, J. Wergedal, D. Baylink, 1990, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Selective deficiency of 1,25-dihydroxycholecalciferol. A cause of isolated skeletal resistance to parathyroid hormone.

M. Haussler, R. Robertson, S. Metz, 1977, The New England journal of medicine.

Identification of quantitative trait loci that regulate obesity and serum lipid levels in MRL/MpJ × SJL/J inbred mice Published, JLR Papers in Press, October 27, 2005.

S. Mohan, D. Baylink, Hongrun Yu, 2006, Journal of Lipid Research.

S. Mohan, D. Baylink, J. Farley, 1995, Calcified Tissue International.

Postnatal and Pubertal Skeletal Changes Contribute Predominantly to the Differences in Peak Bone Density Between C3H/HeJ and C57BL/6J Mice

L. Donahue, S. Mohan, J. Wergedal, 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Effects of inhibitors of signal transduction pathways on transforming growth factor B1 and osteogenic protein‐1‐induced insulinlike growth factor binding protein‐3 expression in human bone cells

S. Mohan, D. Baylink, K. Sampath, 1997, Journal of cellular physiology.

Effect of combined risedronate and hormone replacement therapies on bone mineral density in postmenopausal women.

A. Chines, E. Eriksen, S. T. Harris, 2001, The Journal of clinical endocrinology and metabolism.

Serum Levels of Insulin-Like Growth Factor (IGF); IGF-Binding Proteins-3, -4, and -5; and Their Relationships to Bone Mineral Density and the Risk of Vertebral Fractures in Postmenopausal Women

S. Mohan, K. Chihara, H. Kaji, 2006, Calcified Tissue International.

Acute Effects of Calcitonin Nasal Spray on Serum C-telopeptide of Type 1 Collagen (CTx) Levels in Elderly Osteopenic Women with Increased Bone Turnover

A. Kriegman, C. Libanati, D. Baylink, 2004, Calcified Tissue International.

Prevention of colorectal cancer with vitamin D

S. Olafsson, C. Jackson, D. Baylink, 2010, Scandinavian journal of gastroenterology.

Studies on regulation of insulin-like growth factor binding protein (IGFBP)-3 and IGFBP-4 production in human bone cells.

S. Mohan, J. Wergedal, D. Baylink, 1992, Acta endocrinologica.

Conditional deletion of IGF-I in osteocytes unexpectedly accelerates bony union of the fracture gap in mice.

D. Baylink, M. Sheng, C. Rundle, 2016, Bone.

Effects of Recombinant Insulin-Like Growth Factor-Binding Protein-4 on Bone Formation Parameters in Mice1.

S. Mohan, N. Miyakoshi, D. Baylink, 1999, Endocrinology.

IGF-binding proteins are multifunctional and act via IGF-dependent and -independent mechanisms.

S. Mohan, D. Baylink, 2002, The Journal of endocrinology.

Structural and functional analysis of the 5'-flanking region of the human insulin-like growth factor binding protein (IGFBP)-4 gene.

S. Mohan, D. Baylink, D. Strong, 1997, Biochimica et biophysica acta.

Pregnancy-associated Plasma Protein-A Regulates Myoblast Proliferation and Differentiation through an Insulin-like Growth Factor-dependent Mechanism*

S. Mohan, Ashok Kumar, D. Baylink, 2005, Journal of Biological Chemistry.

Genetic regulation of femoral bone mineral density: complexity of sex effect in chromosome 1 revealed by congenic sublines of mice.

S. Mohan, J. Wergedal, W. Beamer, 2007, Bone.

Spinal fractures during fluoride therapy for osteoporosis: Relationship to spinal bone density

R. Cruise, J. Wergedal, L. Lindegren, 1992, Osteoporosis International.

The effects of estrone (Ogen) on spinal bone density of postmenopausal women.

H. Genant, J. Gallagher, H. Genant, 1991, Archives of internal medicine.

Monofluorophosphate is hydrolyzed by alkaline phosphatase and mimics the actions of NaF on skeletal tissues,In Vitro

D. Baylink, J. Farley, N. Tarbaux, 2007, Calcified Tissue International.

Dexamethasone enhances the osteogenic effects of fluoride in human TE85 osteosarcoma cellsin vitro

K. Lau, T. Chevalley, D. Baylink, 1996, Calcified Tissue International.

Histomorphometric analysis of iliac crest bone biopsies in placebo-treated versus fluoride-treated subjects

B. Riggs, J. Wergedal, J. Featherstone, 1995, Osteoporosis International.

Incorporation of sodium fluoride into cortical bone does not impair the mechanical properties of the appendicular skeleton in rats

T. Einhorn, E. Faierman, D. Baylink, 1992, Calcified Tissue International.

Phenytoin and fluoride act in concert to stimulate bone formation and to increase bone volume in adult male rats

J. Wergedal, D. Baylink, T. Matsuyama, 1995, Calcified Tissue International.

Fluoride Therapy for Osteoporosis

K. Lau, D. Baylink, 2001 .

Protein Tyrosine Kinase Inhibitors Block the Stimulatory Actions of Phosphotyrosine Phosphatase Inhibitors to Increase Cell Proliferation, Alkaline Phosphatase Activity, and Collagen Synthesis in Normal HumanBone Cells

K. Lau, D. Baylink, H. K. Yoon, 2000, American Journal of Nephrology.

CHAPTER 48 – Fluoride Therapy of Established Osteoporosis

K. Lau, D. Baylink, 1999 .

Fluoride at Mitogenic Doses Induces a Sustained Activation of p44, but Not p42, in Human TE85 Osteosarcoma Cells*

K. Lau, D. Baylink, H. K. Yoon, 1997 .

Fluoride at mitogenic doses induces a sustained activation of p44mapk, but not p42mapk, in human TE85 osteosarcoma cells.

K. Lau, L. W. Wu, L. Graves, 1997, The Journal of clinical endocrinology and metabolism.

Fluoride at mitogenic concentrations increases the steady state phosphotyrosyl phosphorylation level of cellular proteins in human bone cells.

K. Lau, D. Baylink, A. Thomas, 1996, The Journal of clinical endocrinology and metabolism.

Pretreatment with low doses of norethindrone potentiates the osteogenic effects of fluoride on human osteosarcoma cells

D. Baylink, J. Takada, William K.‐H. Lau, 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Theoretical physical chemical studies of the cause of fluoride‐induced osteomalacia

M. Francis, D. Baylink, C. Ritchie, 1990, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Mitogenic action(s) of fluoride on osteoblast line cells: Determinants of the response In Vitro

D. Baylink, J. Farley, S. Hall, 1990, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Fluoride therapy for osteoporosis promotes a progressive increase in spinal bone density

C. Libanati, E. Schulz, D. Baylink, 1990, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Fluoride pharmacokinetics in good and poor responders to fluoride therapy

D. Baylink, M. Kraenzlin, D. Baylink, 1990, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

The effect of prolonged fluoride therapy for osteoporosis: Bone composition and histology

J. Burnell, J. Wergedal, D. Sherrard, 1989 .

Efficacy of long-term fluoride and calcium therapy in correcting the deficit of spinal bone density in osteoporosis.

C. Libanati, E. Schulz, D. Baylink, 1989, Journal of clinical epidemiology.

A proposed mechanism of the mitogenic action of fluoride on bone cells: inhibition of the activity of an osteoblastic acid phosphatase.

K. Lau, D. Baylink, J. Farley, 1989, Metabolism: clinical and experimental.

Vanadate stimulates bone cell proliferation and bone collagen synthesis in vitro.

K. Lau, D. Baylink, H. Tanimoto, 1988, Endocrinology.

The anti-bone-resorptive agent calcitonin also acts in vitro to directly increase bone formation and bone cell proliferation.

D. Baylink, J. Farley, T. Linkhart, 1988, Endocrinology.

Evidence that fluoride-stimulated 3[H]-thymidine incorporation in embryonic chick calvarial cell cultures is dependent on the presence of a bone cell mitogen, sensitive to changes in the phosphate concentration, and modulated by systemic skeletal effectors.

D. Baylink, J. Farley, S. Hall, 1988, Metabolism: clinical and experimental.

Incidence of hip fractures in osteoporotic women treated with sodium fluoride

B. L. Riggs, M. Kleerekoper, P. Meunier, 1987, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Fluoride therapy for osteoporosis: characterization of the skeletal response by serial measurements of serum alkaline phosphatase activity.

J. Wergedal, D. Baylink, J. Farley, 1987, Metabolism: clinical and experimental.

The effects of fluoride therapy on metabolic bone disease. A histologic study.

D. Baylink, D. S. Bernstein, 1967, Clinical orthopaedics and related research.

Effects of calcitonin on bone quality and osteoblastic function

S. Wallach, D. Baylink, J. Farley, 1993, Calcified Tissue International.

Mapping quantitative trait loci that influence blood levels of alkaline phosphatase in MRL/MpJ and SJL/J mice.

S. Mohan, D. Baylink, G. Masinde, 2004, Bone.

The role of IGF system in the rise and fall in bone density with age.

S. Mohan, K. Lau, D. Baylink, 2007, Journal of musculoskeletal & neuronal interactions.

Mapping quantitative trait loci that influence serum insulin-like growth factor binding protein-5 levels in F2 mice (MRL/MpJ X SJL/J).

S. Mohan, Xinmin Li, D. Baylink, 2003, Endocrinology.

changes are different in two inbred mouse strains Mechanical loading-induced gene expression and BMD

S. Mohan, J. Wergedal, C. Kesavan, 2015 .

Mechanical loading-induced gene expression and BMD changes are different in two inbred mouse strains.

S. Mohan, J. Wergedal, C. Kesavan, 2005, Journal of applied physiology.

A time course of bone response to jump exercise in C57BL/6J mice

S. Mohan, Y. Umemura, J. Wergedal, 2002, Journal of Bone and Mineral Metabolism.

Effects of dietary calcium depletion and repletion on dynamic determinants of tibial bone volume in two inbred strains of mice.

L. Donahue, J. Wergedal, W. Beamer, 2000, Bone.

Alkaline phosphatase levels and osteoprogenitor cell numbers suggest bone formation may contribute to peak bone density differences between two inbred strains of mice.

L. Donahue, C. Rosen, H. Dimai, 1998, Bone.

Lack of insulin-like growth factor I exaggerates the effect of calcium deficiency on bone accretion in mice.

S. Mohan, J. Wergedal, Y. Amaar, 2003, Endocrinology.

Formation, mineralization, and resorption of bone in vitamin D-deficient rats.

J. Wergedal, C. Rich, D. Baylink, 1970, The Journal of clinical investigation.

A genomewide screening of N-ethyl-N-nitrosourea-mutagenized mice for musculoskeletal phenotypes.

S. Mohan, J. Wergedal, D. Baylink, 2003, Bone.

The diagnosis and treatment of osteoporosis: future prospects.

S. Mohan, D. Baylink, D. Strong, 1999, Molecular medicine today.

Quantification of skeletal alkaline phosphatase in osteoporotic serum by wheat germ agglutinin precipitation, heat inactivation, and a two-site immunoradiometric assay.

D. Baylink, J. Farley, B. Miller, 1994, Clinical chemistry.

Skeletal alkaline phosphatase activity in serum.

D. Baylink, J. Farley, 1995, Clinical chemistry.

Skeletal alkaline phosphatase activity as a bone formation index in vitro.

D. Baylink, J. Farley, 1986, Metabolism: clinical and experimental.

Improved method for quantitative determination in serum of alkaline phosphatase of skeletal origin.

C. Chesnut, D. Baylink, J. Farley, 1981, Clinical chemistry.

The role of skeletal calcium deficiency in postmenopausal osteoporosis

J. Burnell, C. Chesnut, D. Baylink, 1986, Calcified Tissue International.

Quantitative histological studies on the pathogenesis of uremic bone disease.

J. Wergedal, D. Sherrard, D. Baylink, 1974, The Journal of clinical endocrinology and metabolism.

Increased serum 1,25-dihydroxyvitamin D in idiopathic hypercalciuria.

M. Haussler, D. Sherrard, D. Baylink, 1977, The Journal of laboratory and clinical medicine.

A mouse tumor-derived osteolytic factor stimulates bone resorption by a mechanism involving local prostaglandins production in bone.

S. Mohan, K. Lau, D. Baylink, 1985, Biochimica et biophysica acta.

Analytical and clinical evaluation of the Bio-Rad HPLC kit for measurement of type I collagen cross links

M. Greenwald, C. Libanati, D. Baylink, 2003, Journal of Bone and Mineral Metabolism.

Modifications of the fibroblast growth factor‐2 gene led to a marked enhancement in secretion and stability of the recombinant fibroblast growth factor‐2 protein

Shin-Tai Chen, D. Baylink, S. Kapur, 2007, Journal of cellular biochemistry.

Characterization and assay of tartrate-resistant acid phosphatase activity in serum: potential use to assess bone resorption.

K. Lau, J. Wergedal, F. Singer, 1987, Clinical chemistry.

The Regulation of Endosteal Bone Volume.

D. Baylink, Chung Ching Liu, 1979, Journal of periodontology.

Postmenopausal osteoporosis: proposed roles of defective coupling and estrogen deficiency.

D. Baylink, J. Ivey, 1981, Metabolic bone disease & related research.

Increases in number and size of osteoclasts in response to calcium or phosphorus deficiency in the rat.

J. Wergedal, D. Baylink, E. Thompson, 1975, Endocrinology.

Evidence for the coupling of bone formation to bone resorption in vitro

G. Howard, D. Baylink, B. L. Bottemiller, 1980 .

High Osteoblastic Activity In C3H/HeJ Mice Compared to C57BL/6J Mice Is Associated with Low Apoptosis in C3H/HeJ Osteoblasts

S. Mohan, K. Lau, J. Wergedal, 2006, Calcified Tissue International.

Digit tip regrowth and differential gene expression in MRL/Mpj, DBA/2, and C57BL/6 mice

R. Chadwick, S. Mohan, J. Wergedal, 2007, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

Retroviral‐based gene therapy with cyclooxygenase‐2 promotes the union of bony callus tissues and accelerates fracture healing in the rat

K. Lau, J. Wergedal, Shin-Tai Chen, 2008, The journal of gene medicine.

Studies on regulation of IGF (insulin-like growth factor)-binding protein (IGFBP) 4 proteolysis by pregnancy-associated plasma protein-A (PAPP-A) in cells treated with phorbol ester.

S. Mohan, H. Kita, Shin-Tai Chen, 2004, The Biochemical journal.

BEYOND CARRIER PROTEINS IGF-binding proteins are multifunctional and act via IGF-dependent and -independent mechanisms

S. Mohan, D. Baylink, 2002 .

Studies on the Mechanisms by Which Insulin-like Growth Factor (IGF) Binding Protein-4 (IGFBP-4) and IGFBP-5 Modulate IGF Actions in Bone Cells (*)

S. Mohan, Y. Nakao, D. Baylink, 1995, The Journal of Biological Chemistry.

Structure-Function Analysis of the Human Insulin-like Growth Factor Binding Protein-4*

S. Mohan, D. Baylink, D. Strong, 1998, The Journal of Biological Chemistry.

Osteogenic protein-1 stimulates proliferation and differentiation of human bone cells in vitro.

S. Mohan, J. Wergedal, D. Baylink, 1993, Biochemical and biophysical research communications.

An inhibitory insulin-like growth factor binding protein (In-IGFBP) from human prostatic cell conditioned medium reveals N-terminal sequence identity with bone derived In-IGFBP.

S. Mohan, D. Baylink, T. Linkhart, 1990, The Journal of clinical endocrinology and metabolism.

The 24/25-kDa serum insulin-like growth factor-binding protein is increased in elderly women with hip and spine fractures.

L. Donahue, S. Mohan, C. Rosen, 1992, The Journal of clinical endocrinology and metabolism.

Impaired skeletal growth in mice with haploinsufficiency of IGF-I: genetic evidence that differences in IGF-I expression could contribute to peak bone mineral density differences.

S. Mohan, D. Baylink, 2005, The Journal of endocrinology.

Development of a simple valid method for the complete removal of insulin-like growth factor (IGF)-binding proteins from IGFs in human serum and other biological fluids: comparison with acid-ethanol treatment and C18 Sep-Pak separation.

S. Mohan, D. Baylink, Subburaman Mohan, 1995, The Journal of clinical endocrinology and metabolism.

Isolation of an inhibitory insulin-like growth factor (IGF) binding protein from bone cell-conditioned medium: a potential local regulator of IGF action.

S. Mohan, J. Wergedal, D. Baylink, 1989, Proceedings of the National Academy of Sciences of the United States of America.

Disruption of Four-and-a-Half LIM 2 Decreases Bone Mineral Content and Bone Mineral Density in Femur and Tibia Bones of Female Mice

S. Mohan, K. Govoni, D. Baylink, 2006, Calcified Tissue International.

Mechanical Strain Stimulates ROS Cell Proliferation Through IGF‐II and Estrogen Through IGF‐I

L. Lanyon, S. Mohan, S. Rawlinson, 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Bone repletion in vitro: evidence for a locally regulated bone repair response to PTH treatment.

S. Mohan, D. Baylink, T. Linkhart, 1988, Bone.

Acute reduction in osteoclast number during bone repletion.

J. I. Rader, D. Baylink, H. Gruber, 1982, Metabolic bone disease & related research.

Neuroendocrine modulation of calcitonin and parathyroid hormone in man.

R. Robertson, L. Deftos, S. Metz, 1978, The Journal of clinical endocrinology and metabolism.

Phosphotyrosyl protein phosphatases.

K. Lau, D. Baylink, J. Farley, 1989, The Biochemical journal.

Increased monocyte interleukin-1 activity and decreased vertebral bone density in patients with fasting idiopathic hypercalciuria.

K. Lau, K. Hruska, L. Avioli, 1990, The Journal of clinical endocrinology and metabolism.

Characterization of the receptor for insulin‐like growth factor II in bone cells

S. Mohan, R. Rosenfeld, D. Baylink, 1989, Journal of cellular physiology.

1,25-dihydroxycholecalciferol. Effect on skeletal lesions and plasma parathyroid hormone levels in uremic osteodystrophy.

S. Massry, A. Norman, D. Sherrard, 1974, Archives of internal medicine.

Human Osteoblasts' Proliferative Responses to Strain and 17β‐Estradiol Are Mediated by the Estrogen Receptor and the Receptor for Insulin‐Like Growth Factor I

L. Lanyon, S. Mohan, A. Pitsillides, 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Bone cell mitogenic action of fluoroaluminate and aluminum fluoride but not that of sodium fluoride involves upregulation of the insulin-like growth factor system.

S. Mohan, K. Lau, D. Baylink, 2002, Bone.

Insulin-like growth factors I and II are present in the skeletal tissues of ten vertebrates.

S. Mohan, D. Baylink, C. M. Bautista, 1990, Metabolism: clinical and experimental.

Growth factor-induced proliferation of osteoblasts measured by bromodeoxyuridine immunocytochemistry.

J. Wergedal, D. Baylink, M. Lundy, 1991, Growth factors.

Bovine skeletal growth factor stimulates protein phosphorylation of chicken bone cells in vitro.

K. Lau, D. Baylink, J. Jennings, 1988, The International journal of biochemistry.

Fluid Shear Stress Synergizes with Insulin-like Growth Factor-I (IGF-I) on Osteoblast Proliferation through Integrin-dependent Activation of IGF-I Mitogenic Signaling Pathway*

S. Mohan, K. Lau, D. Baylink, 2005, Journal of Biological Chemistry.

Increased immunoreactive calcitonin in idiopathic hypercalciuria.

B. Roos, D. Baylink, J. Ivey, 1981, Metabolic bone disease & related research.

Increased Immunoreactive CalcitHin in Idiopathic Hypercalciuria

B. Roos, D. Baylink, J. Ivey, 1981 .

Further evidence supporting the phosphate leak hypothesis of idiopathic hypercalciuria.

M. Haussler, D. Sherrard, D. Baylink, 1978, Advances in experimental medicine and biology.

Regulation of plasma 1α,25 dihydroxyvitamin D by calcium and phosphate

M. Haussler, J. Wergedal, D. Baylink, 1975 .

24,25(OH)2D3, bone formation, and bone resorption in vitamin D-deficient, azotemic rats

D. Sherrard, W. Goodman, D. Baylink, 1984, Calcified Tissue International.

Interactions of growth factors present in bone matrix with bone cells: effects on DNA synthesis and alkaline phosphatase.

S. Mohan, K. Lau, J. Wergedal, 1990, Growth factors.

Evidence that anabolic effects of PTH on bone require IGF-I in growing mice.

S. Mohan, N. Miyakoshi, D. Baylink, 2001, Endocrinology.

Estradiol stimulates in vitro the secretion of insulin-like growth factors by the clonal osteoblastic cell line, UMR106.

S. Mohan, D. Baylink, T. Linkhart, 1989, Biochemical and biophysical research communications.

Primary structure of human skeletal growth factor: homology with human insulin-like growth factor-II.

S. Mohan, D. Baylink, T. Linkhart, 1988, Biochimica et biophysica acta.

Expression of a Structurally Unique Osteoclastic Protein-tyrosine Phosphatase Is Driven by an Alternative Intronic, Cell Type-specific Promoter*

J. B. Tillman, K. Lau, D. Baylink, 2003, Journal of Biological Chemistry.

Quantitative trait loci, genes, and polymorphisms that regulate bone mineral density in mouse.

H. Deng, S. Canale, W. Gu, 2009, Genomics.

Effect of insulin-like growth factor-1 (IGF-1) plus alendronate on bone density during puberty in IGF-1-deficient MIDI mice.

S. Mohan, J. Wergedal, Y. Amaar, 2002, Bone.

Systemic administration of insulin-like growth factor (IGF)-binding protein-4 (IGFBP-4) increases bone formation parameters in mice by increasing IGF bioavailability via an IGFBP-4 protease-dependent mechanism.

S. Mohan, N. Miyakoshi, D. Baylink, 2001, Endocrinology.

Lack of a high prevalence of the BB vitamin D receptor genotype in severely osteoporotic women.

M. Fischer, J. Wergedal, D. Baylink, 1995, The Journal of clinical endocrinology and metabolism.

Circulating levels of insulin-like growth factor-I and -II, and IGF-binding protein-3 in inflammation and after parathyroid hormone infusion.

S. Mohan, S. Ljunghall, D. Baylink, 1994, Bone and mineral.

Effects of recombinant insulin-like growth factor-binding protein-4 on bone formation parameters in mice.

S. Mohan, N. Miyakoshi, D. Baylink, 1999, Endocrinology.

Basic science and clinical utility of biochemical markers of bone turnover--a Congress report.

R. Eastell, M. Seibel, S. Epstein, 2009, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

Prevention and treatment of glucocorticoid-induced osteoporosis. A pathogenetic perspective.

C. Libanati, D. Baylink, David J. Baylink, 1992, Chest.

Development of an MFG-based retroviral vector system for secretion of high levels of functionally active human BMP4.

J. Yee, J. Wergedal, J. Polo, 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

The multi-functional role of insulin-like growth factor binding proteins in bone

S. Mohan, K. Govoni, D. Baylink, 2005, Pediatric Nephrology.

Insulin-like growth factor-binding protein-6 produced by human PC-3 prostate cancer cells: isolation, characterization and its biological action.

S. Mohan, D. Baylink, T. Linkhart, 1996, The Journal of endocrinology.

Evidence for a role for insulin-like growth factor binding proteins in glucocorticoid inhibition of normal human osteoblast-like cell proliferation.

S. Mohan, T. Chevalley, D. Baylink, 1996, European journal of endocrinology.

Structure and characterization of the human insulin-like growth factor binding protein (IGFBP)-6 promoter: identification of a functional retinoid response element.

D. Baylink, T. Linkhart, D. Strong, 2001, Biochimica et biophysica acta.

Transgenic overexpression of pregnancy-associated plasma protein-A in skeletal muscle of mice increases myofiber size and central nucleation in sedentary muscle and promotes muscle regeneration in the injured muscle.

M. Chen, S. Mohan, J. Wergedal, 2012, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

Elevated prostaglandins and suppressed parathyroid hormone associated with hypercalcemia and renal cell carcinoma.

R. P. Robertson, J. Marini, R. Robertson, 1975, The Journal of clinical endocrinology and metabolism.

The renal metabolism of 25-hydroxyvitamin D3 in the rat: Regulation by 1,25-dihydroxyvitamin D3

R. Turner, N. Bell, D. Baylink, 1983, Calcified Tissue International.

Radioligand receptor assay for 25-hydroxyvitamin D2/D3 and 1 alpha, 25-dihydroxyvitamin D2/D3.

M. Haussler, D. Baylink, M. Hughes, 1976, The Journal of clinical investigation.

APPLICATION TO HYPERVITAMINOSIS D

M. Haussler, D. Baylink, P. G. Jones, 1976 .

Radioligand Receptor Assay for 25-Hydroxyvitamin D2/D3 and la,25-Dihydroxyvitamin D2/D3 APPLICATION TO HYPERVITAMINOSIS D MMu

M. Haussler, D. Baylink, P. G. Jones, 2022 .

1,25-Dihydroxyvitamin D3 increases secretion of insulin-like growth factor binding protein-4 (IGFBP-4) by human osteoblast-like cells in vitro and elevates IGFBP-4 serum levels in vivo.

S. Mohan, C. Rosen, S. Scharla, 1993, The Journal of clinical endocrinology and metabolism.

Decreased bone formation, mineralization, and enhanced resorption in calcium-deficient rats.

J. Wergedal, C. Rich, D. Baylink, 1973, The American journal of physiology.

In vitro synthesis of 1 alpha,25-dihydroxycholecalciferol and 24,25-dihydroxycholecalciferol by isolated calvarial cells.

J. Puzas, G. Howard, R. Turner, 1980, Proceedings of the National Academy of Sciences of the United States of America.

In vitro metabolism of 25-hydroxyvitamin D3 by isolated rat kidney cells.

G. Howard, R. Turner, D. Baylink, 1980, Proceedings of the National Academy of Sciences of the United States of America.

Human bone cells in culture metabolize 25-hydroxyvitamin D3 to 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3.

G. Howard, D. Sherrard, R. Turner, 1981, The Journal of biological chemistry.

Construction of a Tc1-like transposon Sleeping Beauty-based gene transfer plasmid vector for generation of stable transgenic mammalian cell clones.

K. Lau, Joseph W Harris, D. Baylink, 2002, Analytical biochemistry.

Treatment with the Oral Growth Hormone Secretagogue MK‐677 Increases Markers of Bone Formation and Bone Resorption in Obese Young Males

S. Mohan, C. Ohlsson, J. Svensson, 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Cobalamin and osteoblast-specific proteins.

K. Lau, F. Singer, R. Carmel, 1988, The New England journal of medicine.

Systemic factors in alveolar bone loss.

J. Wergedal, D. Baylink, K. Yamamoto, 1974, The Journal of prosthetic dentistry.

Inhibition of bone matrix formation, mineralization, and resorption in thyroparathyroidectomized rats.

J. Wergedal, C. Rich, D. Baylink, 1973, The Journal of clinical investigation.

Characterization of Cells Isolated and Cultured from Human Bone

J. Wergedal, D. Baylink, 1984, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Studies of the mechanism by which androgens enhance mitogenesis and differentiation in bone cells.

S. Mohan, J. Wergedal, D. Baylink, 1990, The Journal of clinical endocrinology and metabolism.

Androgens directly stimulate proliferation of bone cells in vitro.

J. Wergedal, R. Turner, D. Baylink, 1989, Endocrinology.

Biochemical markers of bone turnover for the clinical assessment of bone metabolism.

C. Libanati, D. Baylink, A. K. Taylor, 1994, Rheumatic diseases clinics of North America.

Estrogens in the prevention of osteoporosis in postmenopausal women.

H. Genant, J. Gallagher, D. Baylink, 1989, American journal of obstetrics and gynecology.

Identification of mouse Duffy antigen receptor for chemokines (Darc) as a BMD QTL gene.

S. Mohan, J. Wergedal, W. Beamer, 2007, Genome research.

Development of an immunoassay for human serum osteoclastic tartrate-resistant acid phosphatase.

K. Lau, F. Singer, D. Baylink, 1990, The Journal of clinical endocrinology and metabolism.

Evidence that IGF-binding protein-5 functions as a growth factor.

S. Mohan, N. Miyakoshi, D. Baylink, 2001, The Journal of clinical investigation.

Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy.

K. Schulten, B. Boehm, S. Mohan, 2000, Kidney international.

Concentrations of insulin-like growth factor (IGF)-I, -II, and IGF binding protein-4, and -5 in human bone cell conditioned medium do not change with age

S. Mohan, R. Ziegler, J. Pfeilschifter, 2000, Mechanisms of Ageing and Development.

Recombinant human insulin-like growth factor-binding protein-5 stimulates bone formation parameters in vitro and in vivo.

S. Mohan, D. Baylink, K. Lang, 1999, Endocrinology.

Serum Levels of Insulin‐like Growth Factor Binding Proteins (IGFBP)–4 and –5 Correlate with Bone Mineral Density in Growth Hormone (GH)–Deficient Adults and Increase with GH Replacement Therapy

S. Mohan, M. Thorén, A. Hilding, 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Insulin-like growth factor (IGF)-binding proteins in serum--do they have additional roles besides modulating the endocrine IGF actions?

S. Mohan, D. Baylink, J. Pettis, 1996, The Journal of clinical endocrinology and metabolism.

Growth hormone (GH) treatment of GH-deficient children increases serum levels of insulin-like growth factors (IGFs), IGF-binding protein-3 and -5, and bone alkaline phosphatase isoenzyme.

S. Mohan, S. Kanzaki, T. Ono, 1996, Journal of Clinical Endocrinology and Metabolism.

S. Mohan, D. Baylink, J. Farley, 1995, Progress in growth factor research.

Evidence that human bone cells in culture produce insulin-like growth factor-binding protein-4 and -5 proteases.

S. Mohan, S. Hilliker, D. Baylink, 1994, Endocrinology.

Isolation of a novel insulin-like growth factor (IGF) binding protein from human bone: a potential candidate for fixing IGF-II in human bone.

S. Mohan, D. Baylink, C. M. Bautista, 1991, Biochemical and biophysical research communications.

On fluoride and bone strength

C. Turner, T. Einhorn, J. Wergedal, 2004, Calcified Tissue International.

Molecular Mechanism of Action of Fluoride on Bone Cells

K. Lau, D. Baylink, 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Synthesis of 1,25-dihydroxycholecalciferol and 24,25-dihydroxycholecalciferol by calvarial cells. Characterization of the enzyme systems.

J. Puzas, G. Howard, R. Turner, 1987, The Biochemical journal.

Serum levels of insulin-like growth factor (IGF)-I and IGF binding protein (IGFBP)-1 to -6 and their relationship to bone metabolism in osteoporosis patients.

K. Schulten, B. Boehm, S. Mohan, 2003, European journal of internal medicine.

Recombinant human insulin-like growth factor-binding protein-5 stimulates bone formation parameters in vitro and in vivo.

S. Mohan, D. Baylink, K. Lang, 1999, Endocrinology.

Evidence for a lack of functional receptors for nerve growth factor (NGF) in chick bone cells in vitro

K. Lau, D. Baylink, R. Finkelman, 1992, Molecular and Cellular Biochemistry.

Quantitative Trait Loci for Bone Density in Mice: The Genes Determining Total Skeletal Density and Femur Density Show Little Overlap in F2 Mice

S. Mohan, J. Wergedal, D. Baylink, 2002, Calcified Tissue International.

Vitamin D Therapy of Osteoporosis: Plain Vitamin D Therapy Versus Active Vitamin D Analog (D-Hormone) Therapy

K. Lau, D. Baylink, 1999, Calcified Tissue International.

Parathyroid hormone stimulates bone formation and resorption in organ culture: evidence for a coupling mechanism.

G. Howard, R. Turner, J. I. Rader, 1981, Proceedings of the National Academy of Sciences of the United States of America.

Circadian and longitudinal variation of serum C-telopeptide, osteocalcin, and skeletal alkaline phosphatase in C3H/HeJ mice.

S. Mohan, D. Baylink, A. Srivastava, 2001, Bone.

Formation, mineralization, and resorption of bone in hypophosphatemic rats.

J. Wergedal, D. Baylink, M. Stauffer, 1971, The Journal of clinical investigation.

A urine midmolecule osteocalcin assay shows higher discriminatory power than a serum midmolecule osteocalcin assay during short-term alendronate treatment of osteoporotic patients.

S. Mohan, F. Singer, D. Baylink, 2002, Bone.

In vitro evidence that bone formation may be coupled to resorption by release of mitogen(s) from resorbing bone.

D. Baylink, J. Farley, L. A. Murphy, 1987, Metabolism: clinical and experimental.

Calvarial cells synthesize 1 alpha,25-dihydroxyvitamin D3 from 25-hydroxyvitamin D3.

J. Puzas, G. Howard, R. Turner, 1983, Biochemistry.

Intestinal metabolism and portal venous transport of 1,25(OH)2D3, 25(OH)D3, and vitamin D3 in the rat.

K. Lau, J. Wergedal, G. McDonald, 1985, The American journal of physiology.

Nuclear Factor-E2-related Factor-1 Mediates Ascorbic Acid Induction of Osterix Expression via Interaction with Antioxidant-Responsive Element in Bone Cells*

S. Mohan, D. Baylink, W. Xing, 2007, Journal of Biological Chemistry.

The diagnosis and management of osteoporosis

K. Lau, D. Baylink, 2000, Zeitschrift für Rheumatologie.

Conditional deletion of insulin-like growth factor-I in collagen type 1alpha2-expressing cells results in postnatal lethality and a dramatic reduction in bone accretion.

S. Mohan, P. Angel, K. Govoni, 2007, Endocrinology.

Development, validation, and application of a radioimmunoassay for insulin-like growth factor binding protein-5 in human serum and other biological fluids.

S. Mohan, C. Libanati, D. Baylink, 1995, The Journal of clinical endocrinology and metabolism.

Development of a new radioimmunoassay for human osteocalcin: evidence for a midmolecule epitope.

S. Mohan, D. Baylink, A. K. Taylor, 1988, Metabolism: clinical and experimental.

IGF System Components and Their Role in Bone Metabolism

S. Mohan, D. Baylink, 1999 .

Factors affecting bone enzymatic activity in vitamin D-deficient rats.

J. Wergedal, D. Baylink, 1971, The American journal of physiology.

Purification of a skeletal growth factor from human bone.

D. Baylink, J. Farley, 1982, Biochemistry.

Human skeletal alkaline phosphatase. Kinetic studies including pH dependence and inhibition by theophylline.

D. Baylink, J. Farley, J. Ivey, 1980, The Journal of biological chemistry.

Mechanistic study of the cause of decreased blood 1,25-Dihydroxyvitamin D in sepsis

K. Lau, Xiaolei Tang, H. Nguyen, 2019, BMC Infectious Diseases.

Clinical performances of galactosyl hydroxylysine, pyridinoline, and deoxypyridinoline in postmenopausal osteoporosis.

P. Bettica, L. Moro, D. Baylink, 1996, The Journal of clinical endocrinology and metabolism.

Galactosyl Hydroxylysine and Deoxypyridinoline: A Methodological Comparison

P. Bettica, L. Moro, D. Baylink, 1993, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

Biochemical Markers For Bone Formation and Bone Resorption

D. Baylink, M. Kraenzlin, A. K. Taylor, 1989 .

Evidence that human bone cells in culture secrete insulin‐like growth factor (IGF)‐II and IGF binding protein‐3 but not acid‐labile subunit both under basal and regulated conditions

S. Mohan, R. Baxter, D. Baylink, 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Retinoic acid regulates insulin-like growth factor-binding protein expression in human osteoblast cells.

S. Mohan, D. Baylink, T. Linkhart, 1996, Endocrinology.

1,25-Dihydroxyvitamin D3 differentially regulates the production of insulin-like growth factor I (IGF-I) and IGF-binding protein-4 in mouse osteoblasts.

S. Mohan, S. Scharla, D. Baylink, 1991, Endocrinology.

Vitamin D status and metabolism in an ovine pregnancy model: effect of long-term, high-altitude hypoxia.

L. Longo, D. Baylink, R. Goyal, 2016, American journal of physiology. Endocrinology and metabolism.

Characterization of an animal model of pregnancy-induced vitamin D deficiency due to metabolic gene dysregulation.

Lubo Zhang, L. Longo, D. Baylink, 2014, American journal of physiology. Endocrinology and metabolism.

Marrow Stromal Cell-Based Cyclooxygenase 2 Ex Vivo Gene-Transfer Strategy Surprisingly Lacks Bone-Regeneration Effects and Suppresses the Bone-Regeneration Action of Bone Morphogenetic Protein 4 in a Mouse Critical-Sized Calvarial Defect Model

S. Mohan, K. Lau, J. Wergedal, 2009, Calcified Tissue International.

Matrix formation and osteoid maturation in vitamin D-deficient rats made normocalcemic by dietary means

G. Howard, D. Baylink, 1980 .

Characterization of the IGF regulatory system in bone.

S. Mohan, D. Baylink, Subburaman Mohan, 1993, Advances in experimental medicine and biology.

Evidence that sensitivity to growth hormone (GH) is growth period and tissue type dependent: studies in GH-deficient lit/lit mice.

S. Mohan, D. Baylink, Y. Kasukawa, 2003, Endocrinology.

Autocrine regulators of MC3T3‐E1 cell proliferation

S. Mohan, D. Baylink, T. Linkhart, 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Effects of short-term calcium depletion and repletion on biochemical markers of bone turnover in young adult women.

K. Lau, D. Baylink, K. Åkesson, 1998, The Journal of clinical endocrinology and metabolism.

Growth hormone stimulates cortical bone formation in immature hypophysectomized rats.

S. Mohan, D. Baylink, P. Schiltz, 1992, Endocrine research.

Genetic variation in femur extrinsic strength in 29 different inbred strains of mice is dependent on variations in femur cross-sectional geometry and bone density.

C. Ackert-Bicknell, J. Wergedal, W. Beamer, 2005, Bone.

Mouse genetic model for bone strength and size phenotypes: NZB/B1NJ and RF/J inbred strains.

C. Ackert-Bicknell, J. Wergedal, W. Beamer, 2002, Bone.

Spontaneous fracture (sfx): a mouse genetic model of defective peripubertal bone formation.

L. Donahue, R. Bronson, C. Rosen, 2000, Bone.

Comparison of bone formation responses to parathyroid hormone(1-34), (1-31), and (2-34) in mice.

S. Mohan, J. Wergedal, W. Beamer, 2000, Bone.

Development and evaluation of C-telopeptide enzyme-linked immunoassay for measurement of bone resorption in mouse serum.

S. Mohan, N. Miyakoshi, D. Baylink, 2000, Bone.

Development and Application of a Synthetic Peptide-Based Osteocalcin Assay for the Measurement of Bone Formation in Mouse Serum

S. Mohan, J. Wergedal, D. Baylink, 2000, Calcified Tissue International.

Osteoclast Formation in Bone Marrow Cultures from Two Inbred Strains of Mice with Different Bone Densities

L. Donahue, J. Wergedal, C. Rosen, 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Combined magnetic fields increase insulin-like growth factor-II in TE-85 human osteosarcoma bone cell cultures.

F. P. Magee, S. Mohan, J. Ryaby, 1995, Endocrinology.

Regulation of insulin-like growth factor system components by osteogenic protein-1 in human bone cells.

S. Mohan, D. Baylink, T. Sampath, 1995, Endocrinology.

Low‐amplitude, low‐frequency electric field‐stimulated bone cell proliferation may in part be mediated by increased IGF‐II release

S. Mohan, D. Baylink, D. Strong, 1992, Journal of cellular physiology.

Multiple Genetic Loci From CAST/EiJ Chromosome 1 Affect vBMD Either Positively or Negatively in a C57BL/6J Background

S. Mohan, J. Wergedal, W. Beamer, 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Alveolar atrophy and decreased skeletal mass of the radius.

J. Berger, D. Baylink, J. Rosenquist, 1978, International journal of oral surgery.

Effects of medroxyprogesterone acetate on some parameters of calcium metabolism in patients with glucocorticoid-induced osteoporosis.

E. Grecu, D. Baylink, M. E. Spencer, 1991, Bone and mineral.

Sca-1+ Hematopoietic Cell-based Gene Therapy with a Modified FGF-2 Increased Endosteal/Trabecular Bone Formation in Mice.

S. Mohan, D. Gridley, H. Klamut, 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

Development of valid methods to measure insulin-like growth factors-I and -II in bone cell-conditioned medium.

S. Mohan, D. Baylink, T. Linkhart, 1990, Endocrinology.

Influence of dietary vitamin D3 on the circulating concentration of its active metabolites in the chick and rat.

M. Haussler, D. Baylink, S. U. Toverud, 1977, Endocrinology.

Effects of calcium depletion and repletion on serum insulin-like growth factor I and binding protein levels in weanling rats.

K. Lau, D. Baylink, K. Åkesson, 1998, Bone.

Localization of the IGF binding domain and evaluation of the role of cysteine residues in IGF binding in IGF binding protein-4.

S. Mohan, D. Baylink, X. Qin, 2001, The Journal of endocrinology.

Pregnancy-associated plasma protein-A accounts for the insulin-like growth factor (IGF)-binding protein-4 (IGFBP-4) proteolytic activity in human pregnancy serum and enhances the mitogenic activity of IGF by degrading IGFBP-4 in vitro.

S. Mohan, M. Yoo, D. Baylink, 2001, The Journal of clinical endocrinology and metabolism.

Evidence that the interaction between insulin-like growth factor (IGF)-II and IGF binding protein (IGFBP)-4 is essential for the action of the IGF-II-dependent IGFBP-4 protease.

S. Mohan, K. Lau, D. Baylink, 2000, Archives of biochemistry and biophysics.

Studies on human pregnancy-induced insulin-like growth factor (IGF)-binding protein-4 proteases in serum: determination of IGF-II dependency and localization of cleavage site.

S. Mohan, M. Yoo, D. Baylink, 2000, The Journal of clinical endocrinology and metabolism.

Studies on the Role of Human Insulin‐like Growth Factor‐II (IGF‐II)‐Dependent IGF Binding Protein (hIGFBP)‐4 Protease in Human Osteoblasts Using Protease‐Resistant IGFBP‐4 Analogs

S. Mohan, D. Baylink, D. Strong, 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Progesterone and promegestone stimulate human bone cell proliferation and insulin-like growth factor-2 production.

S. Mohan, D. Baylink, D. Strong, 1992, Acta endocrinologica.

Contribution of marrow stromal cells to the regulation of osteoblast proliferation in rats: evidence for the involvement of insulin-like growth factors.

S. Mohan, D. Baylink, D. Simmons, 1991, Bone and mineral.

Measurement of bone mineral content in the term and preterm infant.

D. Baylink, T. Linkhart, N. Vyhmeister, 1987, American journal of diseases of children.

Vitamin D intoxication in an anephric child.

D. Sherrard, D. Baylink, F. Shen, 1975, Annals of internal medicine.

Evidence that fluoride therapy increases trabecular bone density in a peripheral skeletal site.

P. Bettica, C. Libanati, E. Schulz, 1993, The Journal of clinical endocrinology and metabolism.

Characterization of a rapidly responding animal model for fluoride-stimulated bone formation.

D. Baylink, J. Farley, M. Lundy, 1986, Bone.

Insulin‐like Growth Factor (IGF)‐I, ‐II, IGF Binding Proteins (IGFBP)−3, −4, and −5 Levels in the Conditioned Media of Normal Human Bone Cells Are Skeletal Site‐Dependent

S. Mohan, J. Wergedal, D. Baylink, 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Insulin‐like growth factor binding protein–4 inhibits both basal and IGF‐mediated chick pelvic cartilage growth in vitro

S. Mohan, D. Baylink, P. Schiltz, 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Vitamin D deficiency causes a selective reduction in deposition of transforming growth factor beta in rat bone: possible mechanism for impaired osteoinduction.

S. Mohan, K. Lau, N. Bell, 1991, Proceedings of the National Academy of Sciences of the United States of America.

Local ex vivo gene therapy with bone marrow stromal cells expressing human BMP4 promotes endosteal bone formation in mice

J. Wergedal, Shin-Tai Chen, Hairong Peng, 2004, The journal of gene medicine.

Effects of short-term calcium depletion and repletion on biochemical markers of bone turnover in young adult women.

K. Lau, D. Baylink, K. Åkesson, 1998, The Journal of clinical endocrinology and metabolism.

Purification and N-terminal amino acid sequence of the tartrate-resistant acid phosphatase from human osteoclastoma: evidence for a single structure.

S. Mohan, K. Lau, F. Singer, 1990, Biochemical and biophysical research communications.

Purification and N-terminal sequence of two tartrate-resistant acid phosphatases type-5 from the hairy cell leukemia spleen.

S. Mohan, K. Lau, D. Baylink, 1989, Biochemical and biophysical research communications.

Bone mineralization and metabolism of3H-25-hydroxyvitamin D3 in thyroparathyroidectomized rats treated with parathyroid extract

G. Howard, R. Turner, J. I. Rader, 1979, Calcified Tissue International.

Effect of treatment with parathyroid extract on bone parameters and metabolism of 3H-25-hydroxyvitamin D3 in Hypocalcemic Thyroparathyroidectomized Rats

G. Howard, R. Turner, J. I. Rader, 1979 .

Metabolism of 25(OH)D3 to 1,25(OH)2D3 and 24,25(OH)2D3 by chick chorioallantoic cells in culture.

J. Puzas, R. Turner, D. Baylink, 1980, General and comparative endocrinology.

ADAM-9 is an insulin-like growth factor binding protein-5 protease produced and secreted by human osteoblasts.

S. Mohan, G. Hathaway, Y. Amaar, 2002, Biochemistry.

Hypercalcemia induced by prostaglandin E2 in thyroparathyroidectomized but not intact rats.

R. Robertson, D. Baylink, 1977, Prostaglandins.

Plasma prostaglandin E in patients with cancer with and without hypercalcemia.

R. Robertson, S. Metz, K. Cummings, 1976, The Journal of clinical endocrinology and metabolism.

Regulation of insulin-like growth factor binding protein-5, four and a half lim-2, and a disintegrin and metalloprotease-9 expression in osteoblasts.

S. Mohan, K. Govoni, Y. Amaar, 2006, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

Differences in exposure to stimulatory and inhibitory components of the insulin-like growth factor (IGF) system in patients with femoral neck versus trochanteric fracture.

P. Geusens, S. Boonen, S. Mohan, 2005, Age and ageing.

Patients with Van Buchem disease, an osteosclerotic genetic disease, have elevated bone formation markers, higher bone density, and greater derived polar moment of inertia than normal.

J. Wergedal, F. Vanhoenacker, W. Van Hul, 2003, The Journal of clinical endocrinology and metabolism.

A transmembrane osteoclastic protein-tyrosine phosphatase regulates osteoclast activity in part by promoting osteoclast survival through c-Src-dependent activation of NFkappaB and JNK2.

K. Lau, Shin-Tai Chen, D. Baylink, 2007, Archives of biochemistry and biophysics.

Phosphotyrosyl-specific protein phosphatase activity of a bovine skeletal acid phosphatase isoenzyme. Comparison with the phosphotyrosyl protein phosphatase activity of skeletal alkaline phosphatase.

K. Lau, D. Baylink, J. Farley, 1985, The Journal of biological chemistry.

Isolation and purification of a low-molecular-weight skeletal growth factor from human bones.

S. Mohan, D. Baylink, T. Linkhart, 1986, Biochimica et biophysica acta.

Evaluation of the usefulness of serum phosphatases and osteocalcin as serum markers in a calcium depletion-repletion rat model

J. Wergedal, D. Baylink, S. Nishimoto, 1991, Calcified Tissue International.

Multiple osteocalcin fragments in human urine and serum as detected by a midmolecule osteocalcin radioimmunoassay.

S. Mohan, F. Singer, D. Baylink, 1990, The Journal of clinical endocrinology and metabolism.

Quantitative trait loci that harbor genes regulating muscle size in (MRL/MPJ x SJL/J) F(2) mice.

S. Mohan, Xinmin Li, D. Baylink, 2002, Functional & integrative genomics.

Purification and characterization of an acid phosphatase that displays phosphotyrosyl-protein phosphatase activity from bovine cortical bone matrix.

K. Lau, D. Baylink, T. K. Freeman, 1987, The Journal of biological chemistry.

Total body calcium and long-term calcium balance in chronic renal disease.

W. Nelp, D. Sherrard, C. Chesnut, 1973, The Journal of laboratory and clinical medicine.

1,25-Dihydroxyvitamin D: Response to and Production by Bone Cells

J. Puzas, R. Turner, D. Baylink, 1984 .

Bone repletion in calcium deficient rats fed a high calcium diet

J. Wergedal, C. Rich, D. Baylink, 2005, Calcified Tissue Research.

Use of 1,25(OH)2-vitamin D3 to separate 'types' on renal osteodystrophy.

A. Norman, D. Sherrard, A. Brickman, 1977, Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association.

Pore Size Measurements and Some Age-Related Changes in Human Alveolar Bone and Rat Femur

J. Wergedal, D. Baylink, Chung Ching Liu, 1977, Journal of dental research.

Phenytoin increases markers of osteogenesis for the human species in vitro and in vivo.

O. Nakade, K. Lau, D. Baylink, 1995, The Journal of clinical endocrinology and metabolism.

An osteoclastic protein‐tyrosine phosphatase is a potential positive regulator of the c‐Src protein‐tyrosine kinase activity: A mediator of osteoclast activity

K. Lau, Li‐Wha Wu, D. Baylink, 2006, Journal of cellular biochemistry.

Osteocyte-Derived Insulin-Like Growth Factor I Is Not Essential for the Bone Repletion Response in Mice

K. Lau, D. Baylink, M. Sheng, 2015, PloS one.

Truncation of the amino terminus of PTH alters its anabolic activity on bone in vivo.

J. Wergedal, P. Bettica, S. Hilliker, 1996, Bone.

Evaluation of signal transduction mechanisms for the mitogenic effects of prostaglandin E2 in normal human bone cells in vitro

S. Mohan, D. Baylink, R. Fitzsimmons, 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

PTH stimulates the proliferation of TE-85 human osteosarcoma cells by a mechanism not involving either increased cAMP or increased secretion of IGF-I, IGF-II or TGF beta.

S. Mohan, D. Baylink, T. Linkhart, 1992, Bone and mineral.

Differential protein profile in the ear-punched tissue of regeneration and non-regeneration strains of mice: a novel approach to explore the candidate genes for soft-tissue regeneration.

S. Mohan, Xinmin Li, N. Miyakoshi, 2000, Biochimica et biophysica acta.

Growth factors for bone growth and repair: IGF, TGFβ and BMP

Subburaman Mohan, David J. Baylink, S. Mohan, 1996 .

Serum immunoreactive parathyroid hormone and 25-hydroxyvitamin D in patients with uremic bone diseases.

J. Wergedal, D. Sherrard, D. Baylink, 1975, The Journal of clinical endocrinology and metabolism.

Demonstration of reduced mitogenic and osteoinductive activities in demineralized allogeneic bone matrix from vitamin D-deficient rats.

S. Epstein, R. Turner, N. Bell, 1988, The Journal of clinical investigation.

Differential response in alveolar bone osteoclasts residing at two different bone sites

D. Baylink, Chung Ching Liu, 1984, Calcified Tissue International.

Effect of skeletal alkaline phosphatase inhibitors on bone cell proliferation in vitro.

J. Puzas, D. Baylink, J. Farley, 1982, Mineral and electrolyte metabolism.

DISTRIBUTION OF ACID AND ALKALINE PHOSPHATASE ACTIVITY IN UNDEMINERALIZED SECTIONS OF THE RAT TIBIAL DIAPHYSIS

J. Wergedal, D. Baylink, 1969, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

LOSS OF PROTEINPOLYSACCHARIDES AT SITES WHERE BONE MINERALIZATION IS INITIATED

J. Wergedal, D. Baylink, E. Thompson, 1972, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Vitamin D-enhanced osteocytic and osteoclastic bone resorption.

O. J. Whittemore, J. Wergedal, D. Baylink, 1973, The American journal of physiology.

Bone formation by osteocytes.

J. Wergedal, D. Baylink, 1971, The American journal of physiology.

Effect of Residual Dental Pulp Tissue on Regeneration of Dentin‐pulp Complex: An In Vivo Investigation

M. Torabinejad, S. Shabahang, D. Baylink, 2018, Journal of endodontics.

Immobilization and its effect on bone repletion in calcium-deficient rats fed a high calcium diet

J. Wergedal, D. Baylink, Chung Ching Liu, 1978 .

Fluoride directly stimulates proliferation and alkaline phosphatase activity of bone-forming cells.

J. Wergedal, D J Baylink, D. Baylink, 1983, Science.

Combined magnetic fields increased net calcium flux in bone cells

F. P. Magee, J. Ryaby, D. Baylink, 1994, Calcified Tissue International.

Osteogenic Actions of Fluoride: Its Therapeutic Use for Established Osteoporosis

K. Lau, C. Libanati, D. Baylink, 2013 .

Growth factors to stimulate bone formation

Subburaman Mohan, S. Mohan, D. Baylink, 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Bone growth factors.

S. Mohan, D J Baylink, S Mohan, 1991, Clinical orthopaedics and related research.

Osteoblastic Tartrate‐Resistant Acid Phosphatase: Its Potential Role in the Molecular Mechanism of Osteogenic Action of Fluoride

K. Lau, D. Baylink, 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Sodium fluoride does not increase human bone cell proliferation or protein synthesis in vitro

R. Mazess, J. Kopp, P. Robey, 2004, Calcified Tissue International.

Chick osteoblasts contain fluoride-sensitive acid phosphatase activity.

K. Lau, H. Blair, D. Baylink, 1988, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Bone matrix and mineral abnormalities in postmenopausal osteoporosis.

J. Burnell, D. Baylink, C. Chestnut, 1982, Metabolism: clinical and experimental.

Human bone cell phenotypes differ depending on their skeletal site of origin.

J. Wergedal, R. Ziegler, D. Baylink, 1995, The Journal of clinical endocrinology and metabolism.

Inhibitory insulin-like growth factor-binding protein: cloning, complete sequence, and physiological regulation.

S. Mohan, D. Baylink, T. Linkhart, 1990, Molecular endocrinology.

BONE FORMATION AND RESORPTION BY OSTEOCYTES

J. Wergedal, D. Baylink, 1971 .

ImprovedMethodfor QuantitativeDeterminationin Serumof Alkaline

C. Chesnut, D. Baylink, R. Farley, 2004 .

Inhibition of human osteoblast marker gene expression by retinoids is mediated in part by insulin-like growth factor binding protein-6.

S. Mohan, J. Wergedal, D. Baylink, 2001, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

1,25-Dihydroxyvitamin D3 stimulates both alkaline phosphatase gene transcription and mRNA stability in human bone cells.

K. Lau, D. Baylink, D. Strong, 1991, Archives of biochemistry and biophysics.

Stimulation of cellular alkaline phosphatase activity and its messenger RNA level in a human osteosarcoma cell line by 1,25-dihydroxyvitamin D3.

K. Lau, D. Baylink, D. Strong, 1989, Archives of biochemistry and biophysics.

Differential Effects of Two Protein Tyrosine Kinase Inhibitors, Tyrphostin and Genistein, on Human Bone Cell Proliferation as Compared with Differentiation

K. Lau, D. Baylink, H. K. Yoon, 1998, Calcified Tissue International.

Bone-resorption markers galactosyl hydroxylysine, pyridinium crosslinks, and hydroxyproline compared.

F. Singer, P. Bettica, L. Moro, 1992, Clinical chemistry.

Normophosphatemic vitamin D-resistant osteomalacia in a patient with normal calcium and fat absorption.

C. Rich, D. Baylink, M. Waron, 1971, Annals of internal medicine.

A Missense Mutation in the Mouse Col2a1 Gene Causes Spondyloepiphyseal Dysplasia Congenita, Hearing Loss, and Retinoschisis

L. Donahue, R. Bronson, S. Mohan, 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Detecting Novel Bone Density and Bone Size Quantitative Trait Loci Using a Cross of MRL/MpJ and CAST/EiJ Inbred Mice

S. Mohan, J. Wergedal, W. Beamer, 2007, Calcified Tissue International.

Mapping the dominant wound healing and soft tissue regeneration QTL in MRL × CAST

S. Mohan, D. Baylink, Hongrun Yu, 2005, Mammalian Genome.

Insulin-like growth factor regulates peak bone mineral density in mice by both growth hormone-dependent and -independent mechanisms.

L. Donahue, S. Mohan, J. Wergedal, 2003, Endocrinology.

New quantitative trait loci that regulate wound healing in an intercross progeny from DBA/1J and 129×1/SvJ inbred strains of mice

Subburaman Mohan, David J. Baylink, S. Mohan, 2006, Functional & Integrative Genomics.

Peripheral monocyte culture supernatants of menopausal women can induce bone resorption: involvement of cytokines.

M. de Vernejoul, M E Cohen-Solal, A M Graulet, 1993, The Journal of clinical endocrinology and metabolism.

Construction of a BAC Contig for a 3 cM Biologically Significant Region of Mouse Chromosome 1

S. Mohan, K. Lau, W. Beamer, 2004, Genetica.

Mapping genetic loci that regulate lipid levels in a NZB/B1NJ×RF/J intercross and a combined intercross involving NZB/B1NJ, RF/J, MRL/MpJ, and SJL/J mouse strains Published, JLR Papers in Press, May 13, 2007.

S. Mohan, C. Ackert-Bicknell, J. Wergedal, 2007, Journal of Lipid Research.

Calcium deficiency in fluoride-treated osteoporotic patients despite calcium supplementation.

D. Baylink, J. Farley, S. Farley, 1996, The Journal of clinical endocrinology and metabolism.

The effects of the insulin-like growth factors and transforming growth factor β on the jun proto-oncogene family in MC3T3-E1 cells

S. Mohan, D. Baylink, E. Landale, 1994, Calcified Tissue International.

Whole genome microarray analysis of growth hormone-induced gene expression in bone: T-box3, a novel transcription factor, regulates osteoblast proliferation.

R. Chadwick, S. Mohan, K. Govoni, 2006, American journal of physiology. Endocrinology and metabolism.

The Role of Insulin-Like Growth Factor Binding Protein-5 in Bone

S. Mohan, D. Baylink, 1997 .

Effect of aging on stem cells

K. Lau, D. Baylink, M. Sheng, 2017, World journal of experimental medicine.

regulator of osteoblast cell proliferation interacting protein: evidence IGFBP5-IP is a potential Identification and characterization of novel IGFBP5

Shin-Tai Chen, Y. Amaar, D. Baylink, 2016 .

Identification and characterization of novel IGFBP5 interacting protein: evidence IGFBP5-IP is a potential regulator of osteoblast cell proliferation.

S. Mohan, Shin-Tai Chen, Y. Amaar, 2006, American journal of physiology. Cell physiology.

Ras‐Association Domain Family 1 Protein, RASSF1C, Is an IGFBP‐5 Binding Partner and a Potential Regulator of Osteoblast Cell Proliferation

S. Mohan, Y. Amaar, D. Baylink, 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Monofluorophosphate physiology: the effects of fluoride on bone.

D. Baylink, J. Farley, S. Farley, 1983, Caries research.

Global gene expression analysis in the bones reveals involvement of several novel genes and pathways in mediating an anabolic response of mechanical loading in mice

Subburaman Mohan, R. Chadwick, S. Mohan, 2005, Journal of cellular biochemistry.

Characterization of mitogenic activities extracted from bovine bone matrix.

S. Mohan, D. Baylink, G. Wakley, 1986, Bone.

Human skeletal growth factor: characterization of the mitogenic effect on bone cells in vitro.

J. Wergedal, D. Baylink, J. Farley, 1982, Biochemistry.

Endogenous Inhibitor of Bone Cell Proliferation

J. Puzas, G. Howard, D. Baylink, 1981, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Disruption of insulin-like growth factor-I expression in type IIalphaI collagen-expressing cells reduces bone length and width in mice.

S. Mohan, R. Behringer, K. Govoni, 2007, Physiological genomics.

Disruption of the insulin-like growth factor-1 gene in osteocytes impairs developmental bone growth in mice.

L. Bonewald, K. Lau, D. Baylink, 2013, Bone.

Serum insulin-like growth factor-I, insulin-like growth factor binding proteins, and bone mineral content in hyperthyroidism.

S. Mohan, P. Lakatos, P. Stern, 2000, Thyroid : official journal of the American Thyroid Association.

Targeted Overexpression of Osteoactivin in Cells of Osteoclastic Lineage Promotes Osteoclastic Resorption and Bone Loss in Mice

S. Mohan, K. Lau, J. Wergedal, 2012, PloS one.

Humoral Hypercalcemia of Malignancy Activities Produced by Human Lung Tumor Cells Associated β Copurification of Osteolytic and Transforming Growth Factor Updated

S. Mohan, D. Baylink, T. Linkhart, 2006 .

Copurification of osteolytic and transforming growth factor beta activities produced by human lung tumor cells associated with humoral hypercalcemia of malignancy.

S. Mohan, D. Baylink, T. Linkhart, 1989, Cancer research.

An Improved Mouse Sca-1+ Cell-Based Bone Marrow Transplantation Model for Use in Gene- and Cell-Based Therapeutic Studies

D. Gridley, K. Lau, J. Yee, 2006, Acta Haematologica.

Specific binding of estrogen to nuclei from Japanese quail kidney cells.

G. Howard, R. Turner, D. Baylink, 1978, Endocrine research communications.

Progesterone Stimulation of Human Insulin-like Growth Factor-binding Protein-5 Gene Transcription in Human Osteoblasts Is Mediated by a CACCC Sequence in the Proximal Promoter*

D. Baylink, T. Linkhart, D. Strong, 1999, The Journal of Biological Chemistry.

Down‐Regulation of the Serum Stimulatory Components of the Insulin‐like Growth Factor (IGF) System (IGF‐I, IGF‐II, IGF Binding Protein [BP]‐3, and IGFBP‐5) in Age‐Related (Type II) Femoral Neck Osteoporosis

G. Verbeke, S. Boonen, S. Mohan, 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Electron microprobe measurements of bone mineralization rate in vivo.

J. Wergedal, D. Baylink, 1974, The American journal of physiology.

IGF‐II receptor number is increased in TE‐85 osteosarcoma cells by combined magnetic fields

F. P. Magee, J. Ryaby, D. Baylink, 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Estrogen receptor specificity in the regulation of skeletal growth and maturation in male mice.

J. Gustafsson, S. Mohan, C. Ohlsson, 2000, Proceedings of the National Academy of Sciences of the United States of America.

The effects of phosphate depletion on bone.

D. Baylink, E. Morey, J. Ivey, 1978, Advances in experimental medicine and biology.

Acute inhibition of mineralization and stimulation of bone resorption mediated by hypophosphatemia.

J. Wergedal, D. Baylink, W. J. Bruin, 1975, Endocrinology.

The effects of two diphosphonates on bone metabolism in the rat

J. Wergedal, R. Evans, D. Baylink, 1979 .

Insulin-like growth factor system components and the coupling of bone formation to resorption.

S. Mohan, D. Baylink, 1996, Hormone research.

Serum insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5 levels in aging and age-associated diseases.

S. Mohan, D. Baylink, S Mohan, 1997, Endocrine.

Insulin-like Growth Factor-binding Protein 5 (IGFBP-5) Interacts with a Four and a Half LIM Protein 2 (FHL2)*

S. Mohan, Shin-Tai Chen, Y. Amaar, 2002, The Journal of Biological Chemistry.

Microarray analysis of gene expression during the inflammation and endochondral bone formation stages of rat femur fracture repair.

Subburaman Mohan, R. Chadwick, S. Mohan, 2006, Bone.

Hypercalcemia, Excessive Bone Resorption, and Neutrophilia in Mice Bearing a Mammary Carcinoma

D. Baylink, Minako Y. Lee, 1983, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

A critical evaluation of the effect of population size and phenotypic measurement on QTL detection and localization using a large F2 murine mapping population

Shizhong Xu, S. Mohan, R. Quigg, 2006 .

Spontaneous Fractures in the Mouse Mutant sfx Are Caused by Deletion of the Gulonolactone Oxidase Gene, Causing Vitamin C Deficiency

R. Chadwick, L. Donahue, S. Mohan, 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

and width in mice I collagen-expressing cells reduces bone length α type II Disruption of insulin-like growth factor-I expression in

P. Maity, S. Mohan, R. Behringer, 2015 .

Mapping of the chromosome 17 BMD QTL in the F2 male mice of MRL/MpJ × SJL/J

S. Mohan, J. Wergedal, D. Baylink, 2008, Genetica.

A platform of high-efficiency nonviral gene transfer in mouse osteoblast cells in vitro

S. Mohan, D. Baylink, W. Xing, 2006, Molecular biotechnology.

Transforming growth factor beta mediates the estrogen induced inhibition of UMR106 cell growth.

S. Mohan, D. Baylink, T. Linkhart, 1989, Connective tissue research.

Fluid flow shear stress stimulates human osteoblast proliferation and differentiation through multiple interacting and competing signal transduction pathways.

K. Lau, D. Baylink, S. Kapur, 2003, Bone.

Expression of the Fibroblast Growth Factor Receptor Genes in Fracture Repair

K. Lau, J. Wergedal, N. Miyakoshi, 2002, Clinical orthopaedics and related research.

Circulating and skeletal insulin-like growth factor-I (IGF-I) concentrations in two inbred strains of mice with different bone mineral densities.

L. Donahue, S. Mohan, C. Rosen, 1997, Bone.

Osteogenic Protein-1 Stimulates mRNA Levels of BMP-6 and Decreases mRNA Levels of BMP-2 and -4 in Human Osteosarcoma Cells

S. Mohan, D. Baylink, T. Sampath, 1997, Calcified Tissue International.

Analysis of gene expression in the wound repair/regeneration process

Subburaman Mohan, David J. Baylink, S. Mohan, 2001, Mammalian Genome.

Effect of bone matrix-derived growth factors on skull and tibia in the growing rat.

D. Baylink, M. Lundy, C. Engström, 1988, Journal of oral pathology.

Skeletal scintigraphic changes in osteoporosis treated with sodium fluoride: concise communication.

C. Libanati, E. Schulz, D. Baylink, 1984, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Glucocorticoid-induced osteoporosis.

D J Baylink, D. Baylink, 1983, The New England journal of medicine.

Evidence that the inhibition of TE85 human bone cell proliferation by agents which stimulate cAMP production may in part be mediated by changes in the IGF-II regulatory system.

S. Mohan, D. Baylink, 1991, Growth regulation.

Quantitative trait loci for periosteal circumference (PC): identification of single loci and epistatic effects in F2 MRL/SJL mice.

S. Mohan, J. Wergedal, D. Baylink, 2003, Bone.

Quantitative Trait Loci for Femoral and Lumbar Vertebral Bone Mineral Density in C57BL/6J and C3H/HeJ Inbred Strains of Mice

G A Churchill, G. Churchill, L. Donahue, 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Fluoride therapy for the vertebral crush fracture syndrome: A status report

R. Heaney, P. Meunier, D. Baylink, 1990 .

Fluoride therapy for the vertebral crush fracture syndrome: A status report

R. Heaney, P. Meunier, L. J. Melton, 1989, Annals of internal medicine.

Effect of beta-aminopropionitrile on bone mechanical properties.

D. Spengler, D. Baylink, J. Rosenquist, 1977, The Journal of bone and joint surgery. American volume.

Fluoride and bovine bone extract influence cell proliferation and phosphatase activities in human bone cell cultures.

K. Lau, J. Wergedal, D. Baylink, 1988, Clinical orthopaedics and related research.

Quantitative trait loci that harbor genes regulating muscle size in (MRL/MPJ × SJL/J) F2 mice

S. Mohan, Xinmin Li, D. Baylink, 2002, Functional & Integrative Genomics.

Alterations in calcium, phosphorus and C-terminal parathyroid hormone levels in equine acute renal disease.

H. D. Liggitt, C. Hawker, W. Bayly, 1986, The Cornell veterinarian.

Genetic control of the rate of wound healing in mice

Shizhong Xu, Subburaman Mohan, Shizhong Xu, 2001, Heredity.

Chromosomal regions harboring genes for the work to femur failure in mice

Shizhong Xu, S. Mohan, J. Wergedal, 2002, Functional & Integrative Genomics.

Gene expression between a congenic strain that contains a quantitative trait locus of high bone density from CAST/EiJ and its wild-type strain C57BL/6J

S. Mohan, C. Rosen, Xinmin Li, 2002, Functional & Integrative Genomics.

Quantitative Trait Loci for Femoral and Lumbar Vertebral Bone Mineral Density in C57BL/6J and C3H/HeJ Inbred Strains of Mice

G. Churchill, L. Donahue, Ś. Sen, 2001 .

Quantitative trait loci for bone density in C57BL/6J and CAST/EiJ inbred mice

G. Churchill, W. Frankel, L. Donahue, 1999, Mammalian Genome.

Evidence that human bone cells in culture contain binding sites for osteogenic protein-1.

S. Mohan, D. Baylink, R. Malpe, 1994, Biochemical and biophysical research communications.

Human skeletal growth factor stimulates collagen synthesis and inhibits proliferation in a clonal osteoblast cell line (MC3T3‐E1)

S. Mohan, M. Kumegawa, D. Baylink, 1986, Journal of cellular physiology.

Idiopathic hypercalciuria: The 'phosphate leak' hypothesis and the effects of oral phosphate supplement

D. Sherrard, D. Baylink, F. Shen, 1977 .

Identification of genetic loci that regulate bone adaptive response to mechanical loading in C57BL/6J and C3H/HeJ mice intercross.

S. Mohan, J. Wergedal, C. Kesavan, 2006, Bone.

Low dose phenytoin is an osteogenic agent in the rat

J. Wergedal, D. Baylink, H. Gruber, 2004, Calcified Tissue International.

Stimulation of Bone Formation and Bone Resorption by Fluoride in Thyroparathyroidectomized Rats

D. Baylink, Chung Ching Liu, 1977, Journal of dental research.

Changes in markers of bone formation and resorption in a bed rest model of weightlessness

S. Arnaud, D. Baylink, A.K. Taylor, 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Inhibition of bone formation during space flight.

E R Morey, D J Baylink, D. Baylink, 1978, Science.

Increased bone microhardness in fluoride treated rats

J. Wergedal, D. Baylink, K. Yamamoto, 1974, Calcified Tissue Research.

Insulin-like growth factor-I and insulin-like growth factor-II induce c-fos in mouse osteoblastic cells

S. Mohan, D. Baylink, T. Linkhart, 1990, Calcified Tissue International.

Molecular cloning and expression of a unique rabbit osteoclastic phosphotyrosyl phosphatase.

K. Lau, L. W. Wu, D. Baylink, 1996, The Biochemical journal.

Isolation of wound healing/regeneration genes using restrictive fragment differential display-PCR in MRL/MPJ and C57BL/6 mice.

S. Mohan, Xinmin Li, B. Nguyen, 2005, Biochemical and biophysical research communications.

Beta 2-microglobulin is not a bone cell mitogen.

S. Mohan, D. Baylink, J. Jennings, 1989, Endocrinology.

Quantitative trait loci (QTL) for lean body mass and body length in MRL/MPJ and SJL/J F2 mice

S. Mohan, J. Wergedal, Xinmin Li, 2002, Functional & Integrative Genomics.

Predictions on future diagnosis and treatment of osteoporosis: Results and discussion of a recent opinion poll

D. Baylink, H. Gruber, S. Farley, 1995, Calcified Tissue International.

Development and Application of a Serum C-Telopeptide and Osteocalcin Assay to Measure Bone Turnover in an Ovariectomized Rat Model

S. Mohan, J. Wergedal, D. Baylink, 2000, Calcified Tissue International.

In vivo bone formation in fracture repair induced by direct retroviral-based gene therapy with bone morphogenetic protein-4.

Naohisa Miyakoshi, K. Lau, J. Wergedal, 2003, Bone.

A new rat model simulating some aspects of space flight.

R T Turner, R. Turner, E R Morey, 1979, The Physiologist.

Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease.

S. Mohan, M. Thorén, M. Bramnert, 2000, The Journal of clinical endocrinology and metabolism.

Bone cell and hormone changes during bone repletion.

D. Baylink, C. Liu, J. Rader, 1982, Progress in clinical and biological research.

Clinical use of serum and urine bone markers in the management of osteoporosis

M. Maricic, O. Gluck, D. Baylink, 2005, Current medical research and opinion.

Effect of Combined Risedronate and Hormone Replacement Therapies on Bone Mineral Density in Postmenopausal Women

A. Chines, E. Eriksen, S. T. Harris, 2001 .

Parathyroid hormone release is not associated with acute sympathetic arousal in goats.

C. Gale, D. Johnson, D. Baylink, 1979, Endocrine Research Communications.

Ibandronate produces significant, similar antifracture efficacy in North American and European women: new clinical findings from BONE

N. Watts, R. Recker, P. Miller, 2005, Current medical research and opinion.

Hip mineral density in females with a recent hip fracture.

C. Libanati, E. Schulz, D. Baylink, 1992, The Journal of clinical endocrinology and metabolism.

Generalized osteoarthritis associated with increased insulin-like growth factor types I and II and transforming growth factor beta in cortical bone from the iliac crest. Possible mechanism of increased bone density and protection against osteoporosis.

J Dequeker, S. Mohan, J. Dequeker, 1993, Arthritis and rheumatism.

Effects of extracellular calcium on insulin‐like growth factor II in human bone cells

S. Mohan, D. Baylink, Y. Honda, 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Chemical and biological characterization of low-molecular-weight human skeletal growth factor.

S. Mohan, D. Baylink, T. Linkhart, 1986, Biochimica et biophysica acta.

Resorption of bone implants

D. Baylink, J. Rosenquist, 1978 .

Congenic Strains of Mice for Verification and Genetic Decomposition of Quantitative Trait Loci for Femoral Bone Mineral Density

M. Bouxsein, L. Donahue, C. Rosen, 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

S. Mohan, C. Libanati, D. Baylink, 2022 .

Cellular and molecular mechanisms of accelerated fracture healing by COX2 gene therapy: studies in a mouse model of multiple fractures.

Amitava Das, K. Lau, Xiao-Bing Zhang, 2013, Bone.

Identification of Novel Genetic Loci for Bone Size and Mechanosensitivity in an ENU Mutant Exhibiting Decreased Bone Size

J. Wergedal, D. Baylink, Hongrun Yu, 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Evaluation of IGF System Component Levels and Mitogenic Activity of Uremic Serum on Normal Human Osteoblasts

S. Mohan, P. Jehle, F. Keller, 2000, Nephron.

An osteoclastic protein-tyrosine phosphatase may play a role in differentiation and activity of human monocytic U-937 cell-derived, osteoclast-like cells.

K. Lau, D. Baylink, M. Amoui, 2004, American journal of physiology. Cell physiology.

The role of insulin-like growth factor II in magnetic field regulation of bone formation

F. P. Magee, J. Ryaby, A. Weinstein, 1994 .

Picomolar norethindrone in vitro stimulates the cell proliferation and activity of a human osteosarcoma cell line and increases bone collagen synthesis without an effect on bone resorption

D. Baylink, T. Linkhart, K. Demarest, 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Insulin‐Like Growth Factor I Effect on the Number of Osteoblast Progenitors Is Impaired in Ovariectomized Mice

S. Mohan, N. Miyakoshi, D. Baylink, 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

A New Monoclonal Antibody ELISA for Detection and Characterization of C-telopeptide Fragments of Type I Collagen in Urine

V. Srivastava, S. Mohan, D. Baylink, 2001, Calcified Tissue International.

In vitro evidence that local and systemic skeletal effectors can regulate3[H]-thymidine incorporation in chick calvarial cell cultures and modulate the stimulatory actions(s) of embryonic chick bone extract

D. Baylink, J. Farley, J. Vermeiden, 2007, Calcified Tissue International.

The regulation of endosteal bone volume.

D. Baylink, C. Liu, 1979, The Journal of Periodontology.

Exercise and Mechanical Loading Increase Periosteal Bone Formation and Whole Bone Strength in C57BL/6J Mice but Not in C3H/Hej Mice

L. Donahue, Y. Umemura, W. Beamer, 2000, Calcified Tissue International.

Quantitation of growth factors in ossein-mineral-compound.

S. Mohan, J. Wergedal, D. Baylink, 1991, Life sciences.

Extracts of bone contain a potent regulator of bone formation.

G. Howard, D. Baylink, R. Drivdahl, 1982, Biochimica et biophysica acta.

Effect of dichloromethylene diphosphonate on bone metabolism in calcium and phosphorus-depleted rats.

J. Wergedal, R. Evans, D. Baylink, 1983, Mineral and Electrolyte Metabolism.

Bone-derived factors active on bone cells

S. Mohan, D. Baylink, J. Farley, 2006, Calcified Tissue International.

[27] Purification of bovine skeletal growth factor

S. Mohan, D. Baylink, J. Jennings, 1987 .

Excretion of Sweat and Urine Pyridinoline Crosslinks in Healthy Controls and Subjects with Established Metabolic Bone Disease

B. Drinkwater, E. Schwartz, R. Recker, 2001, Clinical chemistry and laboratory medicine.

Normal growth despite GH, IGF-I and IGF-II deficiency.

S. Mohan, E. Hathout, D. Baylink, 1999, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

Development of a synthetic peptide-based tartrate-resistant acid phosphatase radioimmunoassay for the measurement of bone resorption in rat serum

N. Lane, C. Libanati, D. Baylink, 2002, Journal of Bone and Mineral Metabolism.

Genetic dissection of femur breaking strength in a large population (MRL/MpJ x SJL/J) of F2 Mice: single QTL effects, epistasis, and pleiotropy.

S. Mohan, J. Wergedal, Xinmin Li, 2002, Genomics.

Regulation of bone volume is different in the metaphyses of the femur and vertebra of C3H/HeJ and C57BL/6J mice.

L. Donahue, K. Lau, J. Wergedal, 2002, Bone.

Relationship between trabecular vertebral body density and fractures: a quantitative definition of spinal osteoporosis.

J. Wergedal, C. Libanati, E. Schulz, 1988, Metabolism: clinical and experimental.

Serum fluoride and serum osteocalcin levels in response to a novel sustained-release monofluorophosphate preparation: Comparison with plain monofluorophosphate

A. Battmann, H. Resch, C. Libanati, 2005, Osteoporosis International.

Pharmacokinetic profile of a new fluoride preparation: Sustained-release monofluorophosphate

P. Bettica, C. Libanati, D. Baylink, 2004, Calcified Tissue International.

AD Award Number : DAMD 17-011-0744 TITLE : Molecular Genetic Studies of Bone Mechanical Strain and of Pedigrees with Very High Bone Density PRINCIPAL INVESTIGATOR :

D. Baylink, 2022 .

Differential regulation of pregnancy associated plasma protein (PAPP)-A during pregnancy in human and mouse.

S. Mohan, D. Baylink, D. Strong, 2002, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

Up-regulation of the Wnt, Estrogen Receptor, Insulin-like Growth Factor-I, and Bone Morphogenetic Protein Pathways in C57BL/6J Osteoblasts as Opposed to C3H/HeJ Osteoblasts in Part Contributes to the Differential Anabolic Response to Fluid Shear*

K. Lau, C. Kesavan, D. Baylink, 2006, Journal of Biological Chemistry.

Identification of wound healing/regeneration quantitative trait loci (QTL) at multiple time points that explain seventy percent of variance in (MRL/MpJ and SJL/J) mice F2 population.

S. Mohan, Xinmin Li, D J Baylink, 2001, Genome research.

Osteogenic actions of phenytoin in human bone cells are mediated in part by TGF‐β1

O. Nakade, K. Lau, D. Baylink, 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Bayesian Shrinkage Estimation of Quantitative Trait Loci Parameters

Shizhong Xu, S. Mohan, Yuan-Ming Zhang, 2005, Genetics.

Skeletal growth factor is produced by human osteoblast-like cells in culture.

S. Mohan, J. Wergedal, D. Baylink, 1986, Biochimica et biophysica acta.

Commentaryon "Restoration of Bone Mass in the Severely Osteopenic Senescent Rat'

D. Baylink, 2001 .

Coupling of Bone Formation and Bone Resorption: A Model

S. Mohan, J. Ryaby, D. Baylink, 1998 .

A chemical mutagenesis screen to identify modifier genes that interact with growth hormone and TGF-beta signaling pathways.

S. Mohan, D. Baylink, A. Srivastava, 2008, Bone.

Serum 1,25-Dihydroxyvitamin D: An Outcome Prognosticator in Human Sepsis

K. Lau, H. Nguyen, D. Baylink, 2013, PloS one.

Clinical Use of Fluoride in Osteoporosis

D. Baylink, M. Stauffer, S. Mohan, 1990 .

In vivo and in vitro evidence that the high osteoblastic activity in C3H/HeJ mice compared to C57BL/6J mice is intrinsic to bone cells.

K. Lau, J. Wergedal, W. Beamer, 2004, Bone.

Preliminary report: correlation of total body calcium (bone mass), as determined by neutron activation analysis with regional bone mass as determined by photon absorption

R. Mazess, W. Nelp, D. Baylink, 1975 .

Spaceflight Results in Formation of Defective Bone 1

M. Spector, R. Turner, N. Bell, 1985, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Effects of Spaceflight on Structural and Material Strength of Growing Bone

D R Carter, R T Turner, D M Spengler, 1983, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Sustained elevation of pulsatile growth hormone (GH) secretion and insulin-like growth factor I (IGF-I), IGF-binding protein-3 (IGFBP-3), and IGFBP-5 concentrations during 30-day continuous subcutaneous infusion of GH-releasing peptide-2 in older men and women.

S. Mohan, J. Veldhuis, C. Bowers, 2004, The Journal of clinical endocrinology and metabolism.

Femur Mechanical Properties in the F2 Progeny of an NZB/B1NJ × RF/J Cross Are Regulated Predominantly by Genetic Loci That Regulate Bone Geometry

G. Churchill, Renhua Li, C. Ackert-Bicknell, 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

The effect of prolonged fluoride therapy for osteoporosis: bone composition and histology.

J. Burnell, J. Wergedal, D. Sherrard, 1990, Bone.

Evidence that tartrate-resistant acid phosphatases from osteoclastomas and hairy cell leukemia spleen are members of a multigene family.

S. Mohan, K. Lau, D. Baylink, 1991, The International journal of biochemistry.

Progress toward skeletal gene therapy.

K. Lau, H. Klamut, Shin-Tai Chen, 2004, Critical reviews in eukaryotic gene expression.

Covalent interaction between proform of eosinophil major basic protein (proMBP) and pregnancy-associated plasma protein-A (PAPP-A) is a cell-mediated event and required for proMBP inhibition of the catalytic activity of PAPP-A.

S. Mohan, K. Lau, H. Kita, 2004, Archives of biochemistry and biophysics.

Quantitative Assessment of Forearm Muscle Size, Forelimb Grip Strength, Forearm Bone Mineral Density, and Forearm Bone Size in Determining Humerus Breaking Strength in 10 Inbred Strains of Mice

S. Mohan, J. Wergedal, D. Baylink, 2001, Calcified Tissue International.

The increase in spinal bone density that occurs in response to fluoride therapy for osteoporosis is not maintained after the therapy is discontinued

M. Fischer, C. Libanati, D. Baylink, 2005, Osteoporosis International.

Development of a heterologous radioimmunoassay for canine osteocalcin

D. Baylink, J. Gunnet, K. Demarest, 1994, Calcified Tissue International.

Synthetic peptide-based immunoassay for amino-terminal propeptide of type I procollagen: application for evaluation of bone formation.

J. Wergedal, P. Bettica, D. Baylink, 1993, Clinical chemistry.

Rationale for active vitamin D analog therapy in senile osteoporosis

K. Lau, D. Baylink, K. Åkesson, 2009, Calcified Tissue International.

A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group.

D. Kiel, S. Silverman, H. Genant, 2000, The American journal of medicine.

Osteogenic protein-1 stimulates production of insulin-like growth factor binding protein-3 nuclear transcripts in human osteosarcoma cells.

S. Mohan, D. Powell, D. Baylink, 1997, Endocrinology.

Effect of fibrillar structure of pericanalicular and intercanalicular bone on X‐ray absorption

D. Baylink, G. Vose, 1970, The Anatomical record.

Recombinant synthesis of insulin-like growth factor-binding protein-4 (IGFBP-4): Development, validation, and application of a radioimmunoassay for IGFBP-4 in human serum and other biological fluids.

S. Mohan, D. Baylink, E. Landale, 1996, The Journal of clinical endocrinology and metabolism.

Growth factors and electromagnetic fields in bone.

D. Baylink, R. Fitzsimmons, 1994, Clinics in plastic surgery.

HSV-1 amplicon-mediated transfer of 128-kb BMP-2 genomic locus stimulates osteoblast differentiation in vitro.

S. Mohan, C. Kesavan, D. Baylink, 2004, Biochemical and biophysical research communications.

Isolation and partial purification of a putative coupling factor from human bone.

D. Baylink, J. Farley, 1981, Transactions of the Association of American Physicians.

Long-term calcitonin therapy in postmenopausal osteoporosis.

W. Nelp, H. Gruber, C. Chesnut, 1984, Metabolism: clinical and experimental.

Fluoride therapy for osteoporosis: A review of dose response, duration of treatment, and skeletal sites of action

C. Libanati, E. Schulz, D. Baylink, 2007, Calcified Tissue International.

Mouse chromosome 9 quantitative trait loci for soft tissue regeneration: Congenic analysis and fine mapping

Shizhong Xu, S. Mohan, Runzhi Li, 2007, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

Regulation of DNA Synthesis in Chick Calvaria Cells by Factors from Bone Organ Culture

J. Puzas, G. Howard, D. Baylink, 1981, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Cells isolated from embryonic intestine synthesize 1,25-dihydroxyvitamin-D3 and 24,25-dihydroxyvitamin-D3 in culture.

J. Puzas, G. Howard, R. Turner, 1983, Endocrinology.

The Effect of Vitamin D Deficiency on Bone Repletion

D. Baylink, J. Ivey, Chung Ching Liu, 1981 .

Evidence for arrested bone formation during spaceflight

M. Spector, R. Turner, J. Bobyn, 1982 .

Recombinant Human Insulin-Like Growth Factor-Binding Protein-5 Stimulates Bone Formation Parameters in Vitro and in Vivo1.

S. Mohan, D. Baylink, K. Lang, 1999, Endocrinology.

Osteoporosis in corticosteroid-treated asthmatic patients: clinical correlates.

A. Forsythe, R. Zeiger, M. Schatz, 1993, Allergy proceedings : the official journal of regional and state allergy societies.

Phosphotyrosyl protein phosphatases: potential regulators of cell proliferation and differentiation.

K. Lau, D. Baylink, 1993, Critical reviews in oncogenesis.

Osteoporosis associated with pregnancy and lactation: bone biopsy and skeletal features in three patients.

D. Baylink, H. Gruber, D. Baylink, 1984, Metabolic bone disease & related research.

A Correction: Inhibitory Activity in the Conditioned Medium of Embryonic Chick Bones Is Due to Thymidine

S. Mohan, J. Wergedal, D. Baylink, 1984, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Impaired skeletal growth in mice with haploinsufficiency of IGF-I: genetic evidence that differences in IGF-I expression could contribute to peak bone mineral density differences.

S. Mohan, D. Baylink, 2005, The Journal of endocrinology.

Experiment K305: Quantitative analysis of selected bone parameters

C. Cann, R. Turner, D. Baylink, 1981 .

Stanozolol in postmenopausal osteoporosis: therapeutic efficacy and possible mechanisms of action.

W. Nelp, H. Gruber, C. Chesnut, 1983, Metabolism: clinical and experimental.

Quantitative trait loci, genes, and polymorphisms that regulate bone mineral density in mouse.

H. Deng, S. Canale, W. Gu, 2009, Genomics.